Medical Device Patent Infringement
This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
Background
A biomedical engineering firm and a medical device company asserted claims of patent infringement against one another. The patented technology at issue related to minimally disruptive spinal surgery devices and procedures.
Our Analysis
Intensity calculated lost profits and reasonable royalty damages stemming from alleged patent infringement. As part of its work, Intensity performed an analysis of economic factors informing on whether lost profits were an appropriate remedy for the respective patent holders, including demand for the patented product, absence of acceptable non-infringing alternatives, and capacity to exploit demand.
As part its analysis of lost profits, Intensity defined the relevant market for the products at issue and determined sales that the patent holder would have made but for the alleged infringement. Intensity calculated usage of the asserted technology and a sales price that would have occurred but for the alleged infringement. Intensity calculated lost profits on lost sales and determined a reasonable royalty for the remaining units.
As part of its analysis of a reasonable royalty, Intensity conducted an evaluation of each of the 15 Georgia-Pacific factors relating to a hypothetical negotiation for a license to the patented technologies. Intensity evaluated a number of license agreements, licensing policies, commercial relationships, bargaining positions, profitability, contribution of the patented technology, convoyed sales, and other factors informing on the outcome of a hypothetical negotiation between the parties. Intensity calculated an economically appropriate royalty base and royalty rate to determine an appropriate reasonable royalty.
Latest Insights
Article | March 27, 2026
Tiffany Oates Discusses Community Benefit Agreements for Sports Business Journal
Tiffany Oates, Director, recently authored an article for Sports Business Journal, “Sports districts demand more from community benefits agreements. Can teams deliver on their promises?” discussing community benefit agreements (CBAs) and what they reveal about a team’s commitment to the community.
News | March 27, 2026
Secretariat Earns No. 1 Rank in the GAR Power Index for Third Consecutive Year
For the third consecutive year, Secretariat has been ranked No. 1 in the Global Arbitration Review (GAR) Expert Witness Firms’ Power Index 2026, unveiled March 26 at the GAR Awards during Paris Arbitration Week. For the third consecutive year, Secretariat has been ranked No. 1 in the Global Arbitration Review (GAR) Expert Witness Firms’ Power Index 2026, unveiled March 26 at the GAR Awards during Paris Arbitration Week.
News | March 27, 2026
A Systems Approach to“Adequacy”: Human Factors Analysis in Infant Formula and Nutrition Product Litigation
by Farheen Khan Human factors experts play a critical role in infant formula and nutrition‑product litigation because the central questions in these cases—what caregivers perceive, understand, retain, and ultimately do—are questions about human capabilities and limitations, not merely regulatory compliance. In the ongoing infant formula disputes, including the NEC multidistrict litigation and parallel state‑court proceedings, […]
See All Insights
Talk to Our Insightful Experts